Expert Review of Vaccines (ISSN 1476-0584) provides expert commentary on the development, application, and clinical effectiveness of new vaccines. Coverage includes vaccine technology, vaccine adjuvants, prophylactic vaccines, therapeutic vaccines, AIDS vaccines and vaccines for defence against bioterrorism. All articles are subject to rigorous peer-review. 

The vaccine field has been transformed by recent technological advances, but there remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines facilitates decision making to drive forward this exciting field.
Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results
Article Highlights – an executive summary of the author’s most critical points 

Sergio Abrignani, National Institute of Molecular Genetics, Italy 
Jon Kim Andrus, Sabin Vaccine Institute, Washington DC, USA 
Vasso Apostolopoulos, Victoria University, Melbourne 
Philip M Arlen, Precision Biologics, Washington DC, USA 
P Noel Barrett, Baxter BioScience, Austria 
Igor Belyakov, University of Michigan, MI, USA
Alexander Bukreyev, University of Texas Medical Branch, TX, USA 
Myron Christodoulides, University of Southampton, UK 
John Clemens, UCLA Fielding School of Public Health, USA 
Angus G Dalgleish, St George's Hospital Medical School, UK 
Ronald W Ellis, FutuRx Ltd, Israel
Gregory Glenn, Novavax, MD, USA 
Michael Good, Griffith University, Queensland, Australia 
Stephen Hoffman, Sanaria Inc., MD, USA 
JU Igietseme, CDC Atlanta, GA, USA 
Odile Launay, Paris Descartes University, Cochin Hospital, Paris, France 
Camille Locht, Institut Pasteur de Lille, France 
Alex Loukas, James Cook University, Australia 
Umesh Parashar, Centers for Disease Control and Prevention, Atlanta, Georgia, USA 
Andrew J Pollard, University of Oxford, UK 
Shabir Madhi, National Institute for Communicable Diseases, Johannesburg, South Africa 
Jan Poolman, Johnson & Johnson, Leiden, Netherlands 
Punnee Pitisuttithum, Mahidol University, Bangkok, Thailand 
Rino Rappuoli, Novartis Vaccines, Italy 
Steven G Reed, Infectious Disease Research Institute, WA, USA 
Gus Rimmelzwaan, Erasmus Medical Centre, Rotterdam, The Netherlands 
Larisa Rudenko, Institute of Experimental Medicine, Saint Petersburg, Russia 
Suryaprakash Sambhara, CDC Atlanta, GA, USA 
Alessandro Sette, La Jolla Institute for Allergy and Immunology, CA, USA 
Leonard A. Smith, US Army Medical Research Institute of Infectious Diseases, MD, USA 
De-chu Christopher Tang, International Vaccine Institute, Seoul, Korea 
Ralph A Tripp, The University of Georgia, GA, USA 
Takafumi Tsuboi, Ehime University, Ehime, Japan 
Jeffrey Ulmer, GSK Vaccines, MD, USA 
David B Weiner, University of Pennsylvania School of Medicine, PA, USA 
Annelies Wilder-Smith, Lee Kong Chian School of Medicine, Singapore 
Feng-Cai Zhu, Jiangsu Provincial Center for Disease Control and Prevention, China